Study of Clevidipine Assessing Its Postoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-2)
Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to establish the efficacy of of clevidipine versus placebo in
treating postoperative hypertension. Approximately 100 patients with postoperative
hypertension undergoing coronary artery bypass grafting (CABG), off-pump coronary artery
bypass (OPCAB) or minimally invasive direct coronary artery bypass (MIDCAB) surgery and/or
valve replacement/repair procedures were anticipated to be randomly assigned to one of two
treatment groups: clevidipine or placebo.